Elrose Labs (Elroselabs Inc.)


Welcome to the PulseAid listing for the Elrose Labs drug offered from Elroselabs Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Elroselabs Inc.
NON-PROPRIETARY NAME: Conzerol
SUBSTANCE NAME: SILICON DIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM BROMIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-11-16
END MARKETING DATE: 0000-00-00


Elrose Labs HUMAN OTC DRUG Details:

Item DescriptionElrose Labs from Elroselabs Inc.
LABELER NAME: Elroselabs Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6(mg/28.3mg; mg/28.3mg; [hp_X]/28.3mg; mg/28.3mg; mg/28.3mg)
START MARKETING DATE: 2015-11-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70223-001_9032434c-247f-4875-bc69-44a7cde91528
PRODUCT NDC: 70223-001
APPLICATION NUMBER:

Other SILICON DIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Elroselabs Inc.Elrose Labs